Cargando…
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
We recently reviewed the status of peptide and nonpeptide agonists and antagonists for the V(1a), V(1b) and V(2) receptors for arginine vasopressin (AVP) and the oxytocin receptor for oxytocin (OT). In the present review, we update the status of peptides and nonpeptides as: (i) research tools and (i...
Autores principales: | Manning, M, Misicka, A, Olma, A, Bankowski, K, Stoev, S, Chini, B, Durroux, T, Mouillac, B, Corbani, M, Guillon, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490377/ https://www.ncbi.nlm.nih.gov/pubmed/22375852 http://dx.doi.org/10.1111/j.1365-2826.2012.02303.x |
Ejemplares similares
-
Role of Oxytocin and Vasopressin in Neuropsychiatric Disorders: Therapeutic Potential of Agonists and Antagonists
por: Cid-Jofré, Valeska, et al.
Publicado: (2021) -
Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists
por: Stadler, Beatrix, et al.
Publicado: (2020) -
Vasopressin and oxytocin expression in hypothalamic supraoptic nucleus and plasma electrolytes changes in water-deprived male Meriones libycus
por: Boumansour, Lydia, et al.
Publicado: (2021) -
The Constitutively Active V2 Receptor Mutants Conferring NSIAD Are Weakly Sensitive to Agonist and Antagonist Regulation
por: Tenenbaum, Julie, et al.
Publicado: (2009) -
Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones
por: Szalai, Laura, et al.
Publicado: (2022)